BUSINESS● LOW4d ago · Oct 9, 2026, 8:40 PM
CytoMed Therapeutics receives Nasdaq notice over minimum bid price deficiency
Seeking Alpha Tech · north america
CytoMed Therapeutics has received a notice from Nasdaq regarding a deficiency in its minimum bid price. This signifies that the company is not meeting certain listing requirements.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS2m agoNetflix is laying off roughly 6% of its workforceCNBCBUSINESS8m agoTullow Oil: the slow collapse of a former pillar of African oilJeune Afrique